Advicenne nominates Dr David Horn Solomon for election to its Board as Chairman alongside Dr Luc-André Granier remaining as CEO

– FRANCE, Nîmes – Advicenne (BSE: ADVIC, EPA: ADVIC), a speciality pharmaceutical company focused on the development and commercialization of therapeutic products for rare kidney disease, today announced its intention to appoint Dr David Horn Solomon as Chairman of its Board of Directors alongside Dr Luc-André Granier who intends to remain CEO as well as a member of the Board of Directors.…